Ultima-PEG-MGF 2mg Ultima Peptides

£76.00

PEG-MGF 2mg by Ultima Peptides is a pegylated mechano-growth factor variant investigated for its sustained activity profile and enhanced tissue research applications.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Ultima-PEG-MGF 2mg Ultima Peptides
Ultima-PEG-MGF 2mg Ultima Peptides
£76.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Ultima-PEG-MGF: Compound Profile

PEG-MGF 2mg by Ultima Peptides is a pegylated variant of mechano-growth factor (MGF), a splice variant of insulin-like growth factor-1 (IGF-1) that is naturally expressed in response to mechanical muscle stress. The polyethylene glycol (PEG) modification in PEG-MGF extends the compound’s half-life and stability compared to native MGF, making it particularly valuable for extended research protocols. Researchers at Stroid UK Shop can investigate this peptide’s unique properties in cellular models where sustained growth factor signalling is of interest.

Research Applications

Scientific investigations with PEG-MGF focus on its role in cellular repair mechanisms and anabolic signalling pathways. The pegylation process enhances the peptide’s resistance to proteolytic degradation, allowing researchers to examine prolonged activation of MGF-specific pathways in muscle and connective tissue models. Studies have explored how this modified growth factor interacts with satellite cell activation and muscle protein synthesis pathways. Researchers examining PEG-MGF peptides often investigate its potential advantages over non-pegylated variants in experimental protocols requiring extended observation periods.

Technical Specifications

PEG-MGF 2mg Product Details
Parameter Specification
Product Name Ultima-PEG-MGF 2mg
Manufacturer Ultima Peptides
Quantity 2mg per vial
Form Lyophilised powder
Storage -20°C (lyophilised), 2-8°C (reconstituted)
Solubility Bacteriostatic water or sterile saline

This specification profile enables researchers working with SARMs and other anabolic research compounds to incorporate PEG-MGF into comparative studies examining different growth factor mechanisms. The 2mg presentation provides sufficient material for multiple experimental runs while maintaining compound integrity through proper storage protocols. Advanced researchers often combine PEG-MGF studies with investigations of peptides that target complementary anabolic pathways.

Compliance Notice

PEG-MGF is intended strictly for in-vitro laboratory research purposes only. This product is not for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure compliance with institutional guidelines and applicable regulations when conducting studies with this peptide.

Related